ClinConnect ClinConnect Logo
Search / Trial NCT05520151

Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies

Launched by CENTRE HOSPITALIER INTERCOMMUNAL ROBERT BALLANGER · Aug 25, 2022

Trial Information

Current as of November 09, 2025

Recruiting

Keywords

Cystectomy, Nephrectomy, Laparotomies Reduction Of Postoperative Complications

ClinConnect Summary

This clinical trial is looking at how a special oral supplement called Oral Impact might help patients before they have major urological surgeries, like cystectomies (removal of the bladder) or nephrectomies (removal of a kidney). The goal is to see if taking this supplement can reduce complications after surgery and help patients recover more quickly, so they spend less time in the hospital.

To participate, you need to be at least 18 years old and scheduled for one of these surgeries. You should also be able to take the Oral Impact supplement for seven days before your surgery. However, if you have a weakened immune system, certain infections, or are undergoing urgent surgery, you wouldn’t be eligible. If you join the trial, you can expect to be part of a study that aims to improve outcomes for patients undergoing these types of surgeries, and you'll be contributing to valuable research that could benefit others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age and older
  • Scheduled major urological surgery: scheduled: cystectomy, nephrectomy, other laparotomies.
  • Having expressed their free and informed consent.
  • Affiliated to a social security scheme
  • Exclusion Criteria:
  • Immune deficiency.
  • HIV infection.
  • Curative surgery for chronic urinary tract infection.
  • Urgent surgery.
  • Inability to take oral impact 7 days before surgery.
  • Unstable psychiatric state.
  • Infection with COVID 19 during postoperative stay.

About Centre Hospitalier Intercommunal Robert Ballanger

The Centre Hospitalier Intercommunal Robert Ballanger is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in Aulnay-sous-Bois, France, this hospital is committed to improving patient care through innovative research initiatives and collaboration with various medical professionals. As a clinical trial sponsor, the Centre Hospitalier Intercommunal Robert Ballanger aims to enhance medical knowledge and treatment options across diverse therapeutic areas, ensuring a focus on patient safety and ethical standards throughout its research endeavors.

Locations

Aulnay Sous Bois, France

Montreuil, France

Patients applied

0 patients applied

Trial Officials

Serge NDOKO, MD

Principal Investigator

Robert ballanger

MAtthieu CAMBY, MD

Principal Investigator

Centre Hospitalier Intercommunal André Grégoire

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials